Correlation Engine 2.0
Clear Search sequence regions


  • amh receptor (1)
  • androgen (3)
  • diagnosis (2)
  • female (1)
  • glycoprotein (1)
  • gonads (1)
  • humans (1)
  • newborn (2)
  • orient (1)
  • ovotesticular dsd (1)
  • placenta (1)
  • sertoli cells (1)
  • serum (3)
  • sex (7)
  • Sizes of these terms reflect their relevance to your search.

    Disorders of sex development (DSD) are conditions where genetic, gonadal, and/or internal/external genital sexes are discordant. In many cases, serum testosterone determination is insufficient for the differential diagnosis. Anti-Müllerian hormone (AMH), a glycoprotein hormone produced in large amounts by immature testicular Sertoli cells, may be an extremely helpful parameter. In undervirilized 46,XY DSD, AMH is low in gonadal dysgenesis while it is normal or high in androgen insensitivity and androgen synthesis defects. Virilization of a 46,XX newborn indicates androgen action during fetal development, either from testicular tissue or from the adrenals or placenta. Recognizing congenital adrenal hyperplasia is usually quite easy, but other conditions may be more difficult to identify. In 46,XX newborns, serum AMH measurement can easily detect the existence of testicular tissue, leading to the diagnosis of ovotesticular DSD. In sex chromosomal DSD, where the gonads are more or less dysgenetic, AMH levels are indicative of the amount of functioning testicular tissue. Finally, in boys with a persistent Müllerian duct syndrome, undetectable or very low serum AMH suggests a mutation of the AMH gene, whereas normal AMH levels orient toward a mutation of the AMH receptor. Copyright © 2020 Josso and Rey.

    Citation

    Nathalie Josso, Rodolfo A Rey. What Does AMH Tell Us in Pediatric Disorders of Sex Development? Frontiers in endocrinology. 2020;11:619

    Expand section icon Mesh Tags

    Expand section icon Substances


    PMID: 33013698

    View Full Text